Combinatorial use of sodium laurate with taurine or L-glutamine enhances colonic absorption of rebamipide, poorly absorbable antiulcer drug, without any serious histopathological mucosal damages

Masateru Miyake, Yoshikazu Oka, Takanori Minami, Hajime Toguchi, Masaaki Odomi, Ken Ichi Ogawara, Kazutaka Higaki, Toshikiro Kimura

Research output: Contribution to journalArticle

26 Citations (Scopus)


We previously reported that the combinatorial use of sodium laurate (C12) with several amino acids such as taurine (Tau) and L-glutamine (L-Gln) enhanced the colonic absorption of phenol red with attenuating the local toxicity caused by C12. However, even these amino acids could not protect epithelial cells from being damaged if the mucosal damage got worse to the coagulation necrosis by an excessive dose of C12. Comparing C12 with sodium caprate (C10), used in drug products marketed, 100 μmol C10 was needed to exert the similar absorption-enhancement of rebamipide, a poorly absorbable antiulcer drug, to that by 10 μmol C12, and 100 μmol C10 was obviously more toxic to the mucosa than 10 μmol C12. The combinatorial use of C12 with Tau or L-Gln enhanced the colonic absorption of rebamipide four to nine times larger in AUC than the control. Histopathologic studies clearly showed that Tau and L-Gln exerted the cytoprotective action on epithelial cells suffering from slight damages such as shrinkage and exfoliation, more articulately at 6 h than at 1.5 h after dosing. In conclusion, the combinatorial use of C12 with Tau or L-Gln could lead to a novel formulation improving the bioavailability of poorly absorbable drugs without any serious local damages.

Original languageEnglish
Pages (from-to)911-921
Number of pages11
JournalJournal of Pharmaceutical Sciences
Issue number4
Publication statusPublished - Apr 1 2003



  • Absorption enhancer
  • Cytoprotection
  • Histopathology
  • L-glutamine
  • Local toxicity
  • Sodium laurate
  • Taurine

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this